
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.670 | 1.790 | 0.120 |
Stocks | 98.320 | 98.320 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 19.304 | 19.779 |
Price to Book | 6.325 | 4.043 |
Price to Sales | 2.236 | 2.422 |
Price to Cash Flow | 16.391 | 16.160 |
Dividend Yield | 1.556 | 1.381 |
5 Years Earnings Growth | 10.633 | 12.141 |
Number of long holdings: 70
Number of short holdings: 9
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 9.29 | 867.05 | +1.15% | |
UnitedHealth | US91324P1021 | 7.80 | 511.04 | +2.06% | |
Novo Nordisk B | DK0062498333 | 5.49 | 595.9 | -0.27% | |
Thermo Fisher Scientific | US8835561023 | 5.18 | 530.86 | +1.49% | |
AstraZeneca | GB0009895292 | 5.03 | 11,512.0 | -1.64% | |
Merck&Co | US58933Y1055 | 4.49 | 85.60 | +2.77% | |
Boston Scientific | US1011371077 | 4.41 | 105.67 | +0.30% | |
AbbVie | US00287Y1091 | 3.98 | 197.35 | +0.56% | |
J&J | US4781601046 | 3.73 | 157.89 | +1.87% | |
Sanofi | FR0000120578 | 3.43 | 102.66 | -0.41% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
SE0011309681 | 12.79B | 4.10 | 10.66 | 10.44 | ||
Handelsbanken Global Tema A1 EUR | 4.8B | 3.51 | 8.61 | 10.44 | ||
Handelsbanken Multi Asset 100 A1 E | 2.63B | 3.04 | 4.88 | 7.88 | ||
Sverige Selektiv A1 EUR | 2.44B | 7.44 | 7.56 | 10.50 | ||
Handelsbanken Sverige Selektiv A9 E | 2.44B | 7.52 | 8.54 | 11.48 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review